Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Share News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.45
Bid: 4.30
Ask: 4.60
Change: 0.00 (0.00%)
Spread: 0.30 (6.977%)
Open: 4.45
High: 4.45
Low: 4.45
Prev. Close: 4.45
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eden Research Gets 3AEY Commercial Sale Approval In Bulgaria

Thu, 14th Jan 2016 08:12

LONDON (Alliance News) - Agrochemicals technology company Eden Research PLC on Thursday said 3AEY, its first agrochemical product, has been approved for commercial sale in Bulgaria.

The product, which tackles botrytis disease on grapes, has already been launched in Greece and the approval for Bulgaria will open up the Eastern European country's wine market, one of the top 20 globally, to Eden.

"Authorisation of 3AEY in Bulgaria is an important additional milestone for Eden and its regional commercialisation partner, Redestos. This is now the third of seven countries in the Southern EU zone to grant its approval for the sale and use of our first product," said Sean Smith, Eden's chief executive.

Eden shares were up 12% on the news to 15.5625 pence, one of the best performers in the AIM All-Share early Thursday.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
5 May 2023 12:04

Eden Research losses narrow as it expands product reach

(Sharecast News) - Eden Research reported an increase in revenue in its 2022 preliminary results on Friday, to £1.8m from £1.2m in 2021.

Read more
5 May 2023 10:31

IN BRIEF: Eden Research annual loss narrows as revenue rises

Eden Research PLC - AIM-listed biopesticides and plastic-free formulation technology company for use in the global crop protection, animal health and consumer products industries - Posts revenue of GBP1.8 million for 2022, up from GBP1.2 million in 2021. Pretax loss narrows to GBP2.6 million from GBP3.4 million, as gross profit increases to GBP830,160 from GBP561,237 a year earlier. Looking ahead, says it is working hard to move forward with new products including insecticides, seed treatments, and optimised fungicides.

Read more
17 Apr 2023 15:30

Eden Research receives regulatory authorisation for Mevalone in Poland

(Alliance News) - Eden Research PLC on Monday said its flagship biofungicide treatment Mevalone has received regulatory authorisation in Poland.

Read more
23 Mar 2023 19:36

TRADING UPDATES: Regulatory wins for Eden; Marula AIM listing progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jan 2023 10:19

AIM WINNERS & LOSERS: RA International wins contract; Rosslyn plummets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
30 Jan 2023 10:05

Eden Research flagship biofungicide gains home authorisation in Italy

(Alliance News) - Eden Research PLC on Monday said its flagship product, Mevalone, has received authorisation for home and garden use in Italy.

Read more
10 Jan 2023 15:24

Eden Research set to beat expectations for revenue, losses

(Sharecast News) - Biopesticide and crop protection technology developer Eden Research said in an update on Tuesday that its revenue for 2022 was expected to have increased by 50% to £1.8m - £0.1m ahead of market expectations.

Read more
10 Jan 2023 11:59

IN BRIEF: Eden Research eyes annual revenue to be ahead of guidance

Eden Research PLC - Oxfordshire-based sustainable crop protection and animal health firm - Expects revenue for the year ended on December 31 to be GBP1.8 million, ahead of market expectations of GBP1.7 million and up from GBP1.2 million a year earlier.

Read more
15 Dec 2022 21:39

TRADING UPDATES: Serinus completes rig-up; Xtract concludes JV deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Dec 2022 15:37

Eden Research inks distribution deal with Corteva France

(Sharecast News) - Biopesticides developer Eden Research has signed an agreement with Corteva France, it announced on Thursday, allowing Corteva to market, distribute and sell Eden's fungicide product 'Mevalone' in France on an exclusive basis.

Read more
2 Dec 2022 20:39

TRADING UPDATES: Sunrise secures funds; Bango launches e-distribution

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Oct 2022 21:55

EARNINGS SUMMARY: Eden Research, Fox Marble revenue up; LoopUp down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
26 Sep 2022 11:02

AIM WINNERS & LOSERS: musicMagpie wings clipped; US boost for Eden

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
26 Sep 2022 10:20

IN BRIEF: Eden Research shares surge on US EPA approval

Eden Research PLC - Oxfordshire-based sustainable crop protection and animal health firm - Gets regulatory approval from the United States Environmental Protection Agency for all five petitions it submitted, covering three active ingredients and two formulated products. Ingredients are eugenol, geraniol and thymol, while the two products are Mevalone and Cedroz. Says the approval will bring "significant" revenue opportunities to the company, with total market potential of about EUR94 million for Mevalone and EUR189 million for Cedroz.

Read more
22 Aug 2022 10:59

IN BRIEF: Eden Research expects narrowed loss on interim revenue rise

Eden Research PLC - Oxfordshire-based sustainable crop protection and animal health firm - For the first half of 2022, pretax loss is expected to narrow to GBP1.3 million from GBP1.8 million the year before, as revenue is expected to grow 33% year-on-year to GBP1.0 million from GBP800,000.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.